{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:58:12Z","timestamp":1789905492558,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Development Regional Fund \u2018A way to achieve Europe\u2019 ERDF, Spanish Network for Research in Infectious Diseases","award":["REIPI RD12\/0015"],"award-info":[{"award-number":["REIPI RD12\/0015"]}]},{"name":"European Development Regional Fund \u2018A way to achieve Europe\u2019 ERDF, Spanish Network for Research in Infectious Diseases","award":["RD16\/0016"],"award-info":[{"award-number":["RD16\/0016"]}]},{"name":"Fondo de Investigac\u00edon Sanitaria","award":["070190"],"award-info":[{"award-number":["070190"]}]},{"name":"Fondo de Investigac\u00edon Sanitaria","award":["10\/02021"],"award-info":[{"award-number":["10\/02021"]}]},{"name":"Fondo de Investigac\u00edon Sanitaria","award":["10\/01955"],"award-info":[{"award-number":["10\/01955"]}]},{"name":"Fondo de Investigac\u00edon Sanitaria","award":["10\/00795"],"award-info":[{"award-number":["10\/00795"]}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["0048\/2008"],"award-info":[{"award-number":["0048\/2008"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["CTS-5259"],"award-info":[{"award-number":["CTS-5259"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["CTS210"],"award-info":[{"award-number":["CTS210"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijantimicag.2016.12.013","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T03:11:49Z","timestamp":1488337909000},"page":"498-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes"],"prefix":"10.1016","volume":"49","author":[{"given":"Isabel","family":"Morales-Barroso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"L\u00f3pez-Cerero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Gonz\u00e1lez-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Praena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/653932","article-title":"Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0020","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1128\/AAC.03679-14","article-title":"Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012","volume":"58","author":"Olesen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2013.04.006","article-title":"Outcome of bacteraemia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: impact of microbiological determinants","volume":"67","author":"Rodr\u00edguez-Ba\u00f1o","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/mdr.2014.0261","article-title":"Clinical features and treatment outcomes of bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli sequence type 131","volume":"21","author":"Cho","year":"2015","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0040","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1128\/AAC.00119-14","article-title":"Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a Canadian region with a centralised laboratory system: rapid emergence of the H30-Rx sublineage","volume":"58","author":"Peirano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12879-014-0579-z","article-title":"The role of sequence type (ST) 131 in adult community-onset non-ESBL-producing Escherichia coli bacteraemia","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0055","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia l. Etiology and ecology","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0060","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definition conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0065","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JCM.01468-12","article-title":"Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups","volume":"50","author":"Doumith","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1758-2229.12019","article-title":"The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups","volume":"5","author":"Clermont","year":"2013","journal-title":"Environ Microbiol Rep"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0075","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/AEM.06663-11","article-title":"High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli","volume":"78","author":"Weissman","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0080","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0090","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkt405","article-title":"Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b\/ST131: risk factors and clinical implications","volume":"69","author":"L\u00f3pez-Cerero","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0095","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1128\/JCM.01361-09","article-title":"Transmission of an extended-spectrum-\u03b2-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and emphysematous pyelonephritis","volume":"47","author":"Ender","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0100","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/JCM.00993-11","article-title":"Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death","volume":"49","author":"Owens","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.12.013_bib0105","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/AAC.01065-13","article-title":"The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T15:52:46Z","timestamp":1656863566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0924857917300596"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.12.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}